← All organizations

Ruhrlandklinik University Hospital, Essen, Germany

Academic/Hospital

Also known as: Interstitial and Rare Lung Disease Unit, Ruhrlandklinik University Hospital, Essen, Germany

Highest phase reached

Phase 3

First clinical trial

Apr 16, 2018

Last known activity

Apr 16, 2018

Timeline

No events for the selected filters.

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Recent trials (1)

  • NCT03482752Overall official - principal investigatorPhase 3Apr 16, 2018

Details

Last known activity
Apr 16, 2018